Free Trial

Q32 Bio (QTTB) Competitors

Q32 Bio logo
$2.97 +0.17 (+6.07%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$2.88 -0.09 (-2.86%)
As of 10/24/2025 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

QTTB vs. SXTC, MIST, MCRB, CGEN, ELDN, CCCC, THTX, PEPG, MOLN, and NKTX

Should you be buying Q32 Bio stock or one of its competitors? The main competitors of Q32 Bio include China SXT Pharmaceuticals (SXTC), Milestone Pharmaceuticals (MIST), Seres Therapeutics (MCRB), Compugen (CGEN), Eledon Pharmaceuticals (ELDN), C4 Therapeutics (CCCC), Theratechnologies (THTX), PepGen (PEPG), Molecular Partners (MOLN), and Nkarta (NKTX). These companies are all part of the "pharmaceutical products" industry.

Q32 Bio vs. Its Competitors

China SXT Pharmaceuticals (NASDAQ:SXTC) and Q32 Bio (NASDAQ:QTTB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

In the previous week, China SXT Pharmaceuticals had 1 more articles in the media than Q32 Bio. MarketBeat recorded 3 mentions for China SXT Pharmaceuticals and 2 mentions for Q32 Bio. China SXT Pharmaceuticals' average media sentiment score of 1.10 beat Q32 Bio's score of 0.52 indicating that China SXT Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
China SXT Pharmaceuticals
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Q32 Bio
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

China SXT Pharmaceuticals has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, Q32 Bio has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500.

China SXT Pharmaceuticals has higher revenue and earnings than Q32 Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
China SXT Pharmaceuticals$1.74M89.36-$3.30MN/AN/A
Q32 BioN/AN/A-$47.73M-$4.30-0.69

Q32 Bio has a consensus target price of $12.17, indicating a potential upside of 309.65%. Given Q32 Bio's stronger consensus rating and higher possible upside, analysts clearly believe Q32 Bio is more favorable than China SXT Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
China SXT Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Q32 Bio
1 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.11

China SXT Pharmaceuticals' return on equity of 0.00% beat Q32 Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
China SXT PharmaceuticalsN/A N/A N/A
Q32 Bio N/A -2,709.70%-61.16%

5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. Comparatively, 31.3% of Q32 Bio shares are owned by institutional investors. 4.0% of China SXT Pharmaceuticals shares are owned by company insiders. Comparatively, 40.0% of Q32 Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

China SXT Pharmaceuticals beats Q32 Bio on 7 of the 12 factors compared between the two stocks.

Get Q32 Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTTB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTTB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTTB vs. The Competition

MetricQ32 BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$36.23M$3.46B$6.22B$10.81B
Dividend YieldN/A2.28%5.72%4.80%
P/E Ratio-0.698.7521.9925.53
Price / SalesN/A497.20592.72133.12
Price / CashN/A46.9537.2561.86
Price / Book6.3210.4012.056.61
Net Income-$47.73M-$52.83M$3.34B$277.10M
7 Day Performance-6.31%2.10%1.93%2.57%
1 Month Performance57.98%12.33%7.77%3.79%
1 Year Performance-94.13%14.14%56.40%33.01%

Q32 Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTTB
Q32 Bio
2.6575 of 5 stars
$2.97
+6.1%
$12.17
+309.7%
-93.8%$36.23MN/A-0.6939
SXTC
China SXT Pharmaceuticals
1.0462 of 5 stars
$1.45
-1.9%
N/A-72.3%$171.49M$1.74M0.0090News Coverage
Analyst Forecast
Gap Up
MIST
Milestone Pharmaceuticals
2.8762 of 5 stars
$1.99
flat
$4.50
+126.1%
+31.5%$169.14M$1M-2.3730Analyst Forecast
Gap Up
MCRB
Seres Therapeutics
1.9826 of 5 stars
$19.23
+0.6%
$14.33
-25.5%
+25.7%$167.39M$126.32M-4.18330Analyst Forecast
Gap Up
CGEN
Compugen
1.7712 of 5 stars
$2.24
+21.1%
$4.00
+78.6%
+4.7%$165.09M$27.86M-10.1870News Coverage
Analyst Forecast
Gap Up
High Trading Volume
ELDN
Eledon Pharmaceuticals
2.199 of 5 stars
$2.72
-0.7%
$10.00
+267.6%
-1.7%$164.08MN/A-2.3210Analyst Forecast
Gap Up
CCCC
C4 Therapeutics
3.2395 of 5 stars
$2.11
-6.2%
$8.50
+302.8%
-58.8%$160.13M$35.58M-1.34150News Coverage
Upcoming Earnings
Analyst Forecast
Gap Up
THTX
Theratechnologies
N/A$3.42
+0.9%
N/A+173.5%$157.21M$84.38M-17.99140High Trading Volume
PEPG
PepGen
3.3298 of 5 stars
$4.55
-3.6%
$8.40
+84.6%
-44.5%$154.65MN/A-1.5430Positive News
Analyst Forecast
MOLN
Molecular Partners
1.6367 of 5 stars
$3.87
+1.7%
$8.00
+107.0%
-40.4%$153.42M$5.65M-1.86180News Coverage
Upcoming Earnings
NKTX
Nkarta
2.6468 of 5 stars
$2.26
+4.6%
$13.50
+497.3%
-33.8%$153.41MN/A-1.53140News Coverage
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:QTTB) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners